Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Dissecting FZD4-mediated Signaling involved in Endothelial Blood-brain and Blood-retina Barrier Maintenance

FY 2021-22

Summary
The brain and retina are protected by barriers, formed by cells called endothelial cells, which prevent molecules and cells that may be harmful to these tissues from leaking from blood vessels. Highly coordinated signaling is required to maintain these barriers between tissues and the blood, and their breakdown is a major cause of dysfunction and disease. Frizzled-4 (FZD4) is a cell surface receptor expressed in endothelial cells that gets turned on by secreted signals, such as WNT7A/B and Norrin (NDP), that bind to the receptor. We have observed that when FZD4 is turned on by either NDP or a synthetic antibody drug that mimics NDP, called F4L5.13, the endothelial cell barrier is less leaky and more stable. In fact, in a mouse model of endothelial barrier dysfunction that mimics human retinopathy (eye disease), F4L5.13 can stabilize the blood-retinal barrier which means that F4L5.13 may be a promising therapy to treat barrier dysfunction. How turning on FZD4 with NDP or F4L5.13 leads to barrier protection is largely unknown, however, we observe that barrier stability is achieved very quickly. This suggests that FZD4 initiates signaling events inside the cell that are responsible for the effects we see. One important signaling event that occurs within cells is called phosphorylation, which results in proteins inside the cell being modified to turn on or off. The goal of this proposal is to use a powerful technique called phosphoproteomics to look at all the changes in protein phosphorylation that occur within the cell following the addition of NDP or F4L5.13. Further, we want to determine which of these signaling events caused by FZD4 leads to barrier protection and stabilization. Since dysfunction in FZD4 signaling is related to stroke, neurodegenerative disease, and retinopathy this research has very high potential to help us understand how FZD4 works and what the best proteins are to target with drugs to help protect our brain and eye barriers.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
455103
Name
Thibeault Pierre
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Dissecting FZD4-mediated Signaling involved in Endothelial Blood-brain and Blood-retina Barrier Maintenance
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Blood-Brain And Blood-Retinal Barriers; Cytoskeleton; Endothelial Barrier; Endothelial Cells; Frizzled-4 (Fzd4); Mass Spectrometry; Norrie Disease Protein/Retinopathy; Phosphoproteomics; Vegf Signaling; Wnt/Beta-Catenin Signaling
Abstract
The brain and retina are protected by barriers, formed by cells called endothelial cells, which prevent molecules and cells that may be harmful to these tissues from leaking from blood vessels. Highly coordinated signaling is required to maintain these barriers between tissues and the blood, and their breakdown is a major cause of dysfunction and disease. Frizzled-4 (FZD4) is a cell surface receptor expressed in endothelial cells that gets turned on by secreted signals, such as WNT7A/B and Norrin (NDP), that bind to the receptor. We have observed that when FZD4 is turned on by either NDP or a synthetic antibody drug that mimics NDP, called F4L5.13, the endothelial cell barrier is less leaky and more stable. In fact, in a mouse model of endothelial barrier dysfunction that mimics human retinopathy (eye disease), F4L5.13 can stabilize the blood-retinal barrier which means that F4L5.13 may be a promising therapy to treat barrier dysfunction. How turning on FZD4 with NDP or F4L5.13 leads to barrier protection is largely unknown, however, we observe that barrier stability is achieved very quickly. This suggests that FZD4 initiates signaling events inside the cell that are responsible for the effects we see. One important signaling event that occurs within cells is called phosphorylation, which results in proteins inside the cell being modified to turn on or off. The goal of this proposal is to use a powerful technique called phosphoproteomics to look at all the changes in protein phosphorylation that occur within the cell following the addition of NDP or F4L5.13. Further, we want to determine which of these signaling events caused by FZD4 leads to barrier protection and stabilization. Since dysfunction in FZD4 signaling is related to stroke, neurodegenerative disease, and retinopathy this research has very high potential to help us understand how FZD4 works and what the best proteins are to target with drugs to help protect our brain and eye barriers.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Thibeault, Pierre
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Toronto - $135,000 Grant (2021-22) | Canada Spends